See What HealthDay Can Do For You
Contact Us

Disrupted Sleep Linked to Increased Amyloid-β Production

Sleep deprivation tied to increased overnight amyloid-β-38, -40, -42 levels by 25 to 30 percent

couple in bed

WEDNESDAY, Dec. 13, 2017 (HealthDay News) -- Disrupted sleep is associated with increased amyloid-β production in adults, according to a study published online Dec. 8 in the Annals of Neurology.

Brendan P. Lucey, M.D., from the Washington University School of Medicine in St. Louis, and colleagues examined whether sleep disruption increases soluble amyloid-β using indwelling lumbar catheters to serially sample cerebrospinal fluid while eight participants (aged 30 to 60 years) were sleep-deprived, treated with sodium oxybate, or allowed to sleep normally. Amyloid-β kinetics were measured by infusion with 13C6-leucine.

The researchers found that, compared with controls who were allowed to sleep normally, sleep deprivation correlated with increased overnight amyloid-β-38, amyloid-β-40, and amyloid-β42 levels (25 to 30 percent increases).

"These findings suggest that disrupted sleep increases Alzheimer's disease risk via increased amyloid-β production," the authors write.

Several authors disclosed financial ties to C2N Diagnostics, including receiving royalties for patents and technology.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.